According to the article, "Today, federal and state investigators are threatening civil litigation against pharmaceutical makers that authorities believe have induced Medicare and Medicaid to overpay for prescription drugs by $1 billion or more a year." This article talks about that controversy.
This file is not available for digital download. IRE members may place an order by emailing rescntr@ire.org
